Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.www.abbott.com
72
MENTIONS
63
EPISODES
59
PODCASTS
Search complete. 72 mentions across 63 episodes found for "Abbott Laboratories".
Oct 28, 2026
Charlie RobinsonHOST
And he was found dead in his apartment hours before that meeting was set to take place.
Charlie RobinsonHOST
And Bill Clinton – was paid $500,000 for a speech from Renaissance Capital in Moscow over the sale of Vero Farm to Abbott Laboratories.
Charlie RobinsonHOST
They approved that deal after Bill Clinton gave a speech and received $500,000.
Charlie RobinsonHOST
So there was a lot of pay for play going on.
Nick EadeHOST
Finally, a hold.
Nick EadeHOST
We are downgrading Abbott Laboratories' ticker ABT to hold.
Nick EadeHOST
Abbott has underperformed and cut its guidance for the year, signaling slower growth for several of its key product lines.
Nick EadeHOST
Now we take a deeper dive into our economic call of the week, Fed Forward.
Richard SchusterHOST
His name is David Grossman.
Richard SchusterHOST
He is the founder and CEO of the Grossman Group, whose client roster represents a wide range of industries and some of the world's leading companies, such as Abbott Labs, Amazon, DHL, Lockheed Martin, McDonald's, Microsoft, to name a few.
Richard SchusterHOST
David's been featured... everywhere in the media, NBC, Nightly News, Wall Street Journal, Chicago Sun-Times, Fast Company, Forbes, Fortune, Newsweek, CBS, Money Watch, and many others.
Richard SchusterHOST
He's here with us today to talk about his latest book, The Heartwork of Modern Leadership, Six Differentiators.
Jeanne SparrowHOST
Abbott Laboratories' nutrition business spinoff leaves a billion-dollar question unanswered.
Jeanne SparrowHOST
And Crane's Rachel Herzog joins me for a conversation about the future of retail on State Street.
Rachel HerzogGUEST
I think one key difference between North Michigan Avenue, the Magnificent Mile, and State Street is State Street is a lot more in the central business district, so a lot more dependent on office traffic.
9 MINS LATER
Jeanne SparrowHOST
Connect with a banker today at oldnational.com slash commercial banking.
Jeanne SparrowHOST
Member FDIC.
Jeanne SparrowHOST
Abbott Laboratories is spinning off its nutrition business into a new standalone company, a move winning early praise from Wall Street, but leaving a billion-dollar question unanswered.
Jeanne SparrowHOST
Abbott chief executive Robert Ford says the split will create the world's largest pure-play nutrition company, while allowing Abbott's core healthcare and device business to accelerate sales and boost overall margins.
Jeanne SparrowHOST
Analysts at J.P. Morgan and BTIG agree, noting the nutrition division has weighed down Abbott's overall growth in recent quarters.
Daniel LucasHOST
Abbott Nutrition Business to become a separate company.
Daniel LucasHOST
Abbott Laboratories plans to separate its nutrition business into a publicly traded company.
Daniel LucasHOST
The unit includes Similac Infant Formula and Ensure Nutrition drinks.
Daniel LucasHOST
Reuters reported Abbott expects the separation to be completed in 2027.
David NosalGUEST
I was what was called industrial engineering.
David NosalGUEST
It was actually industrial safety and health at Abbott Laboratories in Chicago.
David NosalGUEST
So I came out of university, only one in my family.
David NosalGUEST
There are only two of us.
Rachel VargheseHOST
The thing is, blood tests also have their limits.
Rachel VargheseHOST
A US company called Crail and its rival Exact Sciences was bought by Abbott Healthcare for over $2 billion this year.
Rachel VargheseHOST
And yet, both struggle at exactly the stage that screening should excel at.
Rachel VargheseHOST
Neither catches even half of stage 1 cancers.
Joshua SchallHOST
Now enjoy my newest podcast episode.
Joshua SchallHOST
Why is Abbott spinning off its eight and a half billion dollar global nutrition empire? If you hadn't caught the headlines yet, healthcare giant Abbott laboratories announced its intention to separate its nutrition business into an independent publicly traded company.
Joshua SchallHOST
Abbott expects to complete the transaction by the end of 2027, subject to customary conditions at which time it would mark one of the largest corporate spinoffs in the last decade.
Joshua SchallHOST
So what's behind this corporate strategy decision? Well, as a strategist with 15 plus years of deep domain expertise in the rapidly expanding healthy nutrition market, and specifically these types of executive level decisions, you could probably view this move in one or two ways.
7 MINS LATER
Joshua SchallHOST
If Abbott Nutrition faces future headline risk, supply chain shocks, or regulatory interventions, it will need adequate financial buffering as the toxic liabilities stay isolated inside the new entity.
Joshua SchallHOST
Regardless, as I mentioned earlier, this business separation is less about absolute risk insulation and more about engineering for aggressive market opportunities.
Joshua SchallHOST
Abbott Laboratories more sharply becomes a pure play medical innovator.
Joshua SchallHOST
Abbott Nutrition streamlines into a focused, cash-rich wellness giant ready to lead the changing metabolic health landscape.
Kristen SweeneyHOST
She also ran a company called Biographies Incorporated, writing clients' memoirs and personal stories and those of their loved ones to help people heal and get their unique voice into the world.
Kristen SweeneyHOST
For the past 15 years, Miki has been in the health tech and pharmaceutical industries, working for Abbott Labs, AbbVie, and now Takeda Pharmaceuticals.
Kristen SweeneyHOST
In her current role, she develops and executes external and internal communications plans within Takeda's plasma-derived therapies division.
Kristen SweeneyHOST
She's also the vice president of the board of trustees for the Fremont District Public Library in Northern Illinois.
John BazarHOST
The more things change, the more things stay the same.
John BazarHOST
There was a shortage of baby formula, and Abbott Nutrition was rushing to create more, get more formula on the shelves.
John BazarHOST
I heard stories of people who, if you have a kid that's about four years old, four or five years old, you maybe had some trauma of driving around trying to find formula at all these different places because it's pretty dire, especially if you couldn't nurse or pump.
John BazarHOST
The number one movie at the box office, Top Gun Maverick, crowd pleaser.
53 more episodes mention Abbott Laboratories.
Create an account to see the whole feed, search across every transcript, and follow the entities you care about.